Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
TheFeel, námestí Smirických, Kostelec n. C. Lesy 28163, Czechia
+31613054419
info@thefeel.org
Copyright © 2023 news.thefeel.org. All Rights Reserved
